Fund Holdings — Blue Owl Capital Holdings LP

Total Portfolio Value:
$500.58M
Total Bought:
$91.94M
Total Sold:
$38.65M
Net Transaction:
+$53.29M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Robinhood Markets, Inc.CL A(HOOD)4,237,4094,237,4090$53.98M$53.98M10.78%$0
Cullinan Therapeutics, Inc.(CGEM)3,419,8422,924,842-495,000$34.85M$49.84M9.96%+$14.99M
Pliant Therapeutics, Inc.(PLRX)3,004,1993,004,1990$54.41M$44.76M8.94%-$9.64M
Engene Holdings Inc
COM
1,234,7602,461,350+1,226,590$11.40M$41.72M8.33%+$30.32M
Tourmaline Bio Inc1,332,3021,447,401+115,099$32.39M$31.99M6.39%-$399.9K
Blue Owl Capital Corporation(OBDC)2,045,0702,045,0700$30.19M$31.45M6.28%+$1.27M
Klaviyo, Inc.COM SER A(KVYO)1,198,2701,198,2700$31.46M$30.53M6.10%-$925.2K
Larimar Therapeutics, Inc.(LRMR)3,414,4683,994,468+580,000$15.54M$30.32M6.06%+$14.78M
Acelyrin Inc2,292,9902,826,028+533,038$17.11M$19.08M3.81%+$1.97M
EverCommerce Inc.(EVCM)01,641,929+1,641,929$0$15.47M3.09%+$15.47M
Repare Therapeutics Inc3,122,4993,122,4990$22.79M$14.71M2.94%-$8.09M
Ultragenyx Pharmaceutical Inc.(RARE)263,238268,238+5,000$12.59M$12.52M2.50%-$64.0K
Keros Therapeutics, Inc.(KROS)352,633172,633-180,000$14.02M$11.43M2.28%-$2.59M
Inozyme Pharma Inc1,270,0271,270,0270$5.41M$9.73M1.94%+$4.32M
Disc Medicine, Inc.(IRON)140,260155,260+15,000$8.10M$9.67M1.93%+$1.57M
Sagimet Biosciences Inc.COM SER A(SGMT)355,3771,673,877+1,318,500$1.93M$9.07M1.81%+$7.15M
Toast, Inc.CL A(TOST)5,890,274322,578-5,567,696$6.04M$8.04M1.61%+$2.00M
E2open Parent Holdings IncCL A1,650,9431,650,9430$7.25M$7.33M1.46%+$82.5K
Mineralys Therapeutics, Inc.(MLYS)568,379541,080-27,299$4.89M$6.99M1.40%+$2.10M
Compass Therapeutics, Inc.(CMPX)2,829,7122,829,7120$4.41M$5.60M1.12%+$1.19M
Ikena Oncology Inc1,953,6163,891,118+1,937,502$3.85M$5.53M1.10%+$1.68M
MoonLake ImmunotherapeuticsCL A(MLTX)65,000100,000+35,000$3.93M$5.02M1.00%+$1.10M
Dell Technologies Inc.SHS(DELL)35,09141,245+6,154$2.68M$4.71M0.94%+$2.02M
Omega Therapeutics Inc1,055,8821,055,8820$3.18M$3.85M0.77%+$675.8K
Aquestive Therapeutics Inc0875,000+875,000$0$3.73M0.74%+$3.73M
Direxion Shs Etf TrDAILY S P BIOTEC340,000490,000+150,000$3.29M$3.57M0.71%+$277.5K
Madrigal Pharmaceuticals, Inc.(MDGL)013,319+13,319$0$3.56M0.71%+$3.56M
Black Diamond Therapeutics I695,000695,0000$1.95M$3.52M0.70%+$1.57M
ADC Therapeutics SASHS(ADCT)733,568733,5680$1.22M$3.29M0.66%+$2.08M
Immunovant, Inc.(IMVT)60,000100,000+40,000$2.53M$3.23M0.65%+$703.2K
Engene Holdings IncW EXP 10 31 202
*W EXP 10/31/202
475,077511,177+36,100$403.8K$2.66M0.53%+$2.25M
Ovid Therapeutics Inc.(OVID)864,822864,8220$2.78M$2.64M0.53%-$147.0K
Braze, Inc.SHS(BRZE)17,726116,153+98,427$941.8K$2.36M0.47%+$1.42M
Syros Pharmaceuticals Inc1,493,252340,855-1,152,397$8.46M$1.82M0.36%-$6.64M
Snowflake Inc.SHS(SNOW)07,819+7,819$0$1.26M0.25%+$1.26M
GitLab Inc.(GTLB)020,706+20,706$0$1.21M0.24%+$1.21M
Blend Labs, Inc.CL A(BLND)361,587361,5870$922.1K$1.18M0.23%+$253.1K
Gohealth IncCL A83,26483,2640$1.11M$875.1K0.17%-$235.6K
Desktop Metal IncCL A750,000750,0000$563.3K$660.0K0.13%+$96.8K
Rallybio Corporation(RLYB)350,240350,2400$837.1K$647.9K0.13%-$189.1K
Enliven Therapeutics Inc025,000+25,000$0$439.8K0.09%+$439.8K
Precision BioSciences, Inc.(DTIL)020,220+20,220$0$274.2K0.05%+$274.2K
Fathom Digital Mfg CorpCL A50,00050,0000$222.9K$230.5K0.05%+$7.6K
Uber Technologies, Inc.(UBER)6,18723,918+17,731$380.9K$78.9K0.02%-$302.0K
Plum Acquisition Corp IiiW EXP 03 31 202666,666666,6660$0$0—$0
Mirum Pharmaceuticals, Inc.(MIRM)10,0130-10,013$295.6K$0—-$295.6K
Blueprint Medicines Corp71,8880-71,888$6.63M$0—-$6.63M
Freeline Therapeutics HldgsADS86,6540-86,654$552.0K$0—-$552.0K
Orchard Therapeutics PlcADS1,599,6600-1,599,660$2.63M$0—-$2.63M
Precision BioSciences, Inc.(DTIL)606,6290-606,629$221.4K$0—-$221.4K
Page 1 of 1
Blue Owl Capital Holdings LP — 13F Holdings — Q1 2024 | TickerTrail